Trial NCT03265080

View at ClinicalTrials.gov 
Org. Study IDs: ADXS-NEO-02

Last trial update was posted on 2023-02-24

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Colon Cancer Metastatic Head and Neck Cancer Metastatic Metastatic Melanoma Metastatic Non-Small Cell Lung Cancer Urothelial Carcinoma

Stopping Reasons

Business decision

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID